Liu H, Li Z, Reindl T, He Z, Qiu X, Golden R
Nat Commun. 2024; 15(1):5179.
PMID: 38898037
PMC: 11187112.
DOI: 10.1038/s41467-024-49161-9.
Maloney B, Carpio K, Bilyeu A, Saunders D, Park S, Pohl A
NPJ Vaccines. 2023; 8(1):172.
PMID: 37932282
PMC: 10628263.
DOI: 10.1038/s41541-023-00765-0.
Li P, Jang J, Hsia C, Groomes P, Lian W, de Wispelaere M
ACS Infect Dis. 2019; 5(3):460-472.
PMID: 30608640
PMC: 6548335.
DOI: 10.1021/acsinfecdis.8b00322.
Goo L, VanBlargan L, Dowd K, Diamond M, Pierson T
PLoS Pathog. 2017; 13(2):e1006178.
PMID: 28207910
PMC: 5312798.
DOI: 10.1371/journal.ppat.1006178.
Ramanathan B, Poh C, Kirk K, McBride W, Aaskov J, Grollo L
PLoS One. 2016; 11(5):e0155900.
PMID: 27223692
PMC: 4880327.
DOI: 10.1371/journal.pone.0155900.
Intra-epidemic evolutionary dynamics of a Dengue virus type 1 population reveal mutant spectra that correlate with disease transmission.
Hapuarachchi H, Koo C, Kek R, Xu H, Lai Y, Liu L
Sci Rep. 2016; 6:22592.
PMID: 26940650
PMC: 4778070.
DOI: 10.1038/srep22592.
Highly divergent dengue virus type 1 genotype sets a new distance record.
Pyke A, Moore P, Taylor C, Hall-Mendelin S, Cameron J, Hewitson G
Sci Rep. 2016; 6:22356.
PMID: 26924208
PMC: 4770315.
DOI: 10.1038/srep22356.
Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.
Liu H, Liu Y, Wang S, Zhang Y, Zu X, Zhou Z
J Virol. 2015; 89(10):5668-86.
PMID: 25762738
PMC: 4442514.
DOI: 10.1128/JVI.00293-15.
The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
VanBlargan L, Mukherjee S, Dowd K, Durbin A, Whitehead S, Pierson T
PLoS Pathog. 2013; 9(12):e1003761.
PMID: 24348242
PMC: 3857832.
DOI: 10.1371/journal.ppat.1003761.
Class II fusion proteins.
Modis Y
Adv Exp Med Biol. 2013; 790:150-66.
PMID: 23884590
PMC: 7123093.
DOI: 10.1007/978-1-4614-7651-1_8.
Flaviviruses: braking the entering.
Pierson T, Kielian M
Curr Opin Virol. 2013; 3(1):3-12.
PMID: 23352692
PMC: 3601797.
DOI: 10.1016/j.coviro.2012.12.001.
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.
Sukupolvi-Petty S, Austin S, Engle M, Brien J, Dowd K, Williams K
J Virol. 2010; 84(18):9227-39.
PMID: 20592088
PMC: 2937608.
DOI: 10.1128/JVI.01087-10.
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
Shrestha B, Brien J, Sukupolvi-Petty S, Austin S, Edeling M, Kim T
PLoS Pathog. 2010; 6(4):e1000823.
PMID: 20369024
PMC: 2848552.
DOI: 10.1371/journal.ppat.1000823.
Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3).
da Silva A, Nascimento E, Cordeiro M, Gil L, Abath F, Montenegro S
PLoS One. 2009; 4(10):e7425.
PMID: 19826631
PMC: 2760205.
DOI: 10.1371/journal.pone.0007425.
Genetic diversity of the E protein of dengue type 3 virus.
Amarilla A, de Almeida F, Jorge D, Alfonso H, de Castro-Jorge L, Nogueira N
Virol J. 2009; 6:113.
PMID: 19627608
PMC: 2720943.
DOI: 10.1186/1743-422X-6-113.
Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins.
Li Z, Khaliq M, Zhou Z, Post C, Kuhn R, Cushman M
J Med Chem. 2008; 51(15):4660-71.
PMID: 18610998
PMC: 2562352.
DOI: 10.1021/jm800412d.
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
Sukupolvi-Petty S, Austin S, Purtha W, Oliphant T, Nybakken G, Schlesinger J
J Virol. 2007; 81(23):12816-26.
PMID: 17881453
PMC: 2169112.
DOI: 10.1128/JVI.00432-07.
Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors.
Yang J, Chen Y, Tu Y, Yen K, Yang Y
PLoS One. 2007; 2(5):e428.
PMID: 17502914
PMC: 1855430.
DOI: 10.1371/journal.pone.0000428.
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
Oliphant T, Nybakken G, Engle M, Xu Q, Nelson C, Sukupolvi-Petty S
J Virol. 2006; 80(24):12149-59.
PMID: 17035317
PMC: 1676294.
DOI: 10.1128/JVI.01732-06.
Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.
Samuel M, Diamond M
J Virol. 2006; 80(19):9349-60.
PMID: 16973541
PMC: 1617273.
DOI: 10.1128/JVI.01122-06.